Although we have demonstrated the correlation between CD44/CD24 ratio, ALDH1+ and the development, metastasis of breast cancer, whether these CSC markers are conserved and how they are dynamically changed during tumor progression have yet to be elucidated. Here, ALDH1A1 is linked to neoplasm.